Management of infections in critically ill returning travellers in the intensive care unit-II: clinical syndromes and special considerations in immunocompromised patients.
Fiche du document
- doi: 10.1016/j.ijid.2016.04.020
- issn: 1201-9712
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ijid.2016.04.020
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/27134159
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1878-3511
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_A25B9CD64B784
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Wayfarers Voyagers TravellersCiter ce document
J. Rello et al., « Management of infections in critically ill returning travellers in the intensive care unit-II: clinical syndromes and special considerations in immunocompromised patients. », Serveur académique Lausannois, ID : 10.1016/j.ijid.2016.04.020
Métriques
Partage / Export
Résumé
This position paper is the second ESCMID Consensus Document on this subject and aims to provide intensivists, infectious disease specialists, and emergency physicians with a standardized approach to the management of serious travel-related infections in the intensive care unit (ICU) or the emergency department. This document is a cooperative effort between members of two European Society of Clinical Microbiology and Infectious Diseases (ESCMID) study groups and was coordinated by Hakan Leblebicioglu and Jordi Rello for ESGITM (ESCMID Study Group for Infections in Travellers and Migrants) and ESGCIP (ESCMID Study Group for Infections in Critically Ill Patients), respectively. A relevant expert on the subject of each section prepared the first draft which was then edited and approved by additional members from both ESCMID study groups. This article summarizes considerations regarding clinical syndromes requiring ICU admission in travellers, covering immunocompromised patients.